0000919574-26-002234.txt : 20260414 0000919574-26-002234.hdr.sgml : 20260414 20260414165315 ACCESSION NUMBER: 0000919574-26-002234 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260414 DATE AS OF CHANGE: 20260414 EFFECTIVENESS DATE: 20260414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Setara Life Sciences Fund LP CENTRAL INDEX KEY: 0002123084 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-580417 FILM NUMBER: 26861424 BUSINESS ADDRESS: STREET 1: 215 PARK AVENUE SOUTH STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 9173557830 MAIL ADDRESS: STREET 1: 215 PARK AVENUE SOUTH STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0002123084 Setara Life Sciences Fund LP 215 PARK AVENUE SOUTH 11TH FLOOR NEW YORK NY NEW YORK 10003 9173557830 DELAWARE None None Limited Partnership true 2025 - Setara Capital Management LLC 215 PARK AVENUE SOUTH 11TH FLOOR NEW YORK NY NEW YORK 10003 Executive Officer Promoter Investment Manager - Setara Capital GP LLC 215 PARK AVENUE SOUTH 11TH FLOOR NEW YORK NY NEW YORK 10003 Executive Officer Promoter General Partner Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 false true true true true false 0 Indefinite 0 Indefinite false 0 0 true 0 true 0 true The Investment Manger recieves customary management fees. false Setara Life Sciences Fund LP /s/ Nathan Sadeghi-Nejad Nathan Sadeghi-Nejad Chief Investment Officer of the Investment Manager 2026-04-14